Biomedical Grant Writing Services
Bioscience Advising prides itself on a long-held, specific focus on biomedical grant writing services. The single largest provider of biomedical research funding (> 95%) is the National Institutes of Health (NIH), consisting of 27 institutes and centers, although private philanthropies (e.g, American Heart Association, American Cancer Association, etc.) Its founder, Dr. Curt Balch, has published various commentaries regarding the current misfortune of biomedical research in the U.S., due to decreasing publicly available funding.
- Cancer biology
- Metabolism (cancer-aberrant and glucohomeostasis)
- Molecular biology
- Pharmacology/drug discovery
- Signal Transduction
- Tumor microenvironment
Our Approach to Biomedical Grant Writing
Our approach to biomedical grant preparation includes initial writing of the research narrative, abstract and specific aims page, for approval by the customer, prior to the preparation of the entire application.
Throughout the grant writing process, we maintain constant contact with the client via telephone, Facetime, Google audio/visual chatting, Skype, etc. We believe this is the best approach to ensuring the two parties’ agreed-upon approach to presenting the results, hypotheses, and research strategy (i.e., “being on the same page”).
We have over 20 years experience creating and submitting grant applications for a variety of public agencies, including:
- SBIR/STTR cross-agency opportunities (Department of Defense, Department of Energy, NASA, etc.)
We’re also skilled in creating and submitting grant applications to private organizations such as:
In addition to his editing and consulting work with Bioscience Advising, Curt’s current research interests lie in the design/screening of biomarker-driven targeted therapeutics. He conducts this research in collaboration with Dr. Amit Tiwari (University of Toledo Medical Center) and Drs. Yon Hui Kim and Seung Yoon Nam (both of the National Cancer Center, Seoul, Korea), and joint efforts with Dr. Tom Chittenden (Harvard Medical School, WuXi NextCode) in the dual disciplines of evolutionary mutagenesis and science policy.
Thus, while fully operating Bioscience Advising, Curt remains active in the biomedical research community, striving to contribute to the improvement of human health.